Effects of puerarin on the Akt signaling pathway in bovine preadipocyte differentiation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Puerarin has the potential of regulating the differentiation of preadipocytes, but its mechanism of action has not yet been elucidated. Adipocytes found in adipose tissue, the main endocrine organ, are the main sites of lipid deposition, and are widely used as a cell model in the study of in vitro fat deposition. This study aimed to investigate the effects of puerarin on adipogenesis in vitro. Methods: Puerarin was added to the culture medium during the process of adipogenesis. The proliferation and differentiation of bovine preadipocytes was measured through cell viability and staining with oil red O. The content of triacylglycerol was measured using a triglyceride assay kit. The mRNA and protein expression levels of adipogenic genes, peroxisome proliferator-activated receptor-γ (PPARγ) and CCAAT/enhancer-binding protein-α, were measured using quantitative real-time polymerase chain reaction and western blotting, respectively. Results: The addition of puerarin significantly increased adipogenesis of bovine preadipocytes and enhanced the mRNA and protein level expression of PPARγ (p<0.01). The expression of P-Akt increased after adipogenic hormonal induction, whereas puerarin significantly increased PPARγ expression by promoting the Akt signaling component, P-Akt. The mechanism of adipogenesis was found to be related to the phosphorylation level of Ser473, which may activate the downstream signaling of the Akt pathway. Conclusion: Puerarin was able to promote the differentiation of preadipocytes and improve fat deposition in cattle. The mechanism of adipogenesis was found to be related to the phosphorylation level of Ser473.
Abstract
Objective: Puerarin has the potential of regulating the differentiation of preadipocytes, but its mechanism of action has not yet been elucidated. Adipocytes found in adipose tissue, the main endocrine organ, are the main sites of lipid deposition, and are widely used as a cell model in the study of in vitro fat deposition. This study aimed to investigate the effects of puerarin on adipogenesis in vitro. Methods: Puerarin was added to the culture medium during the process of adipogenesis. The proliferation and differentiation of bovine preadipocytes was measured through cell viability and staining with oil red O. The content of triacylglycerol was measured using a triglyceride assay kit. The mRNA and protein expression levels of adipogenic genes, peroxisome proliferator-activated receptor-γ (PPARγ) and CCAAT/enhancer-binding protein-α, were measured using quantitative real-time polymerase chain reaction and western blotting, respectively. Results: The addition of puerarin significantly increased adipogenesis of bovine preadipocytes and enhanced the mRNA and protein level expression of PPARγ (p<0.01). The expression of P-Akt increased after adipogenic hormonal induction, whereas puerarin significantly increased PPARγ expression by promoting the Akt signaling component, P-Akt. The mechanism of adipogenesis was found to be related to the phosphorylation level of Ser473, which may activate the downstream signaling of the Akt pathway. Conclusion: Puerarin was able to promote the differentiation of preadipocytes and improve fat deposition in cattle. The mechanism of adipogenesis was found to be related to the phosphorylation level of Ser473.
참고문헌 (30)
- Alessi MC, "Production of plasminogen activator inhibitor 1 by human adipose tissue : Possible link between visceral fat accumulation and vascular disease", Diabetes, 46, pp.860~867 (1997)[DOI]
- Avram MM, "Subcutaneous fat in normal and diseased states 3. Adipogenesis : from stem cell to fat cell", J Am Acad Dermatol, 56, pp.472~492 (2007)[DOI]
- Camp HS, "Adipogenesis and fat-cell function in obesity and diabetes", Trends Mol Med, 8, pp.442~447 (2002)[DOI]
- Fėve, B., "Adipogenesis : Cellular and molecular aspects", Best Pract Res Clin Endocrinol Metab, 19, pp.483~499 (2005)[DOI]
- Lundgren CH, "Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease", Circulation, 93, pp.106~110 (1996)[DOI]
- Macdougald OA, "Adipogenesis : forces that tip the scales", Trends Endocrinol Metab, 13, pp.5~11 (2002)[DOI]
- Rosen ED, "Adipocytes as regulators of energy balance and glucose homeostasis", Nature, 444, pp.847~853 (2006)[DOI]
- Margawati ET, "A global strategy of using molecular genetic information to improve genetics in livestock", Reprod Domest Anim, 47, pp.7~9 (2012)[DOI]
- Robelin J, "Cellularity of bovine adipose tissues : developmental changes from 15 to 65 percent mature weight", J Lipid Res, 22, pp.452~457 (1981)
- Cianzio DS, "Adipose tissue growth and cellularity : changes in bovine adipocyte size and number", J Anim Sci, 60, pp.970~976 (1985)[DOI]
- Du M, "Cellular signaling pathways regulating the initial stage of adipogenesis and marbling of skeletal muscle", Meat Sci, 86, pp.103~109 (2010)[DOI]
- Jung HW, "The root extract of Pueraria lobata and its main compound, puerarin, prevent obesity by increasing the energy metabolism in skeletal muscle", Nutrients, 9, pp.E33~ (2017)[DOI]
- Zheng G, "Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice", PloS One, 10, pp.e0122925~ (2015)[DOI]
- Wang N, "Puerarin promotes osteogenesis and inhibits adipogenesis in vitro", Chin Med, 8, pp.17~ (2013)[DOI]
- Lee OH, "Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells", BioFactors, 36, pp.459~467 (2010)[DOI]
- Xu ME, "The study of anti-metabolic syndrome effect of puerarin in vitro", Life Sci, 77, pp.3183~3196 (2005)[DOI]
- Prasain JK, "The Chinese Pueraria root extract(Pueraria lobata)ameliorates impaired glucose and lipid metabolism in obese mice", Phytomedicine, 20, pp.17~23 (2012)[DOI]
- Linhart HG, "C", EBPalpha is required for differentiation of white, but not brown, adipose tissue, 2001, pp.98, 12532~12537
- Lefterova MI, "PPAR gamma and C", EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale, 2008, pp.22, 2941~2952
- Sahiel AR, "Signaling pathways in insulin action : molecular targets of insulin resistance", J Clin Invest, 106, pp.165~169 (2000)[DOI]
- Franke TF, "PI3K : downstream AKTion blocks apoptosis", Cell, 88, pp.435~437 (1997)[DOI]
- Burgering BM, "Protein kinase B(c-Akt)in phosphatidylinositol-3-OH kinase signal transduction", Nature, 376, pp.599~602 (1995)[DOI]
- Hajduch E, "Protein kinase B(PKB", Akt)--a key regulator of glucose transport, 2001, pp.492, 199~203
- Cross DA, "Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B", Nature, 378, pp.785~789 (1995)[DOI]
- Peng XD, "Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2", Genes Dev, 17, pp.1352~1365 (2003)[DOI]
- Kim SP, "Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation", Biochem Biophys Res Commun, 399, pp.55~59 (2010)[DOI]
- Smith PJ, "Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes", J Biol Chem, 263, pp.9402~9408 (1988)
- Cornelius P, "Regulation of adipocyte development", Annu Rev Nutr, 14, pp.99~129 (1994)[DOI]
- Kohn AD, "Expression of a constitutively active Akt Ser", Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation, 1996, pp.271, 31372~31378
- Vlahos CJ, "A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one(LY294002)", J Biol Chem, 269, pp.5241~5248 (1994)